GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Paramount Bed Holdings Co Ltd (TSE:7817) » Definitions » Debt-to-EBITDA

Paramount Bed Holdings Co (TSE:7817) Debt-to-EBITDA : 0.80 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Paramount Bed Holdings Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Paramount Bed Holdings Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円1,415 Mil. Paramount Bed Holdings Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円4,262 Mil. Paramount Bed Holdings Co's annualized EBITDA for the quarter that ended in Dec. 2023 was 円7,124 Mil. Paramount Bed Holdings Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.80.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Paramount Bed Holdings Co's Debt-to-EBITDA or its related term are showing as below:

TSE:7817' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.24   Med: 0.47   Max: 1.07
Current: 0.38

During the past 13 years, the highest Debt-to-EBITDA Ratio of Paramount Bed Holdings Co was 1.07. The lowest was 0.24. And the median was 0.47.

TSE:7817's Debt-to-EBITDA is ranked better than
74.42% of 434 companies
in the Medical Devices & Instruments industry
Industry Median: 1.21 vs TSE:7817: 0.38

Paramount Bed Holdings Co Debt-to-EBITDA Historical Data

The historical data trend for Paramount Bed Holdings Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paramount Bed Holdings Co Debt-to-EBITDA Chart

Paramount Bed Holdings Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.35 0.29 0.25 0.24

Paramount Bed Holdings Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.33 0.35 0.80 0.25

Competitive Comparison of Paramount Bed Holdings Co's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Paramount Bed Holdings Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paramount Bed Holdings Co's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Paramount Bed Holdings Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Paramount Bed Holdings Co's Debt-to-EBITDA falls into.



Paramount Bed Holdings Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Paramount Bed Holdings Co's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1362 + 4602) / 25383
=0.23

Paramount Bed Holdings Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1415 + 4262) / 7124
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Paramount Bed Holdings Co  (TSE:7817) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Paramount Bed Holdings Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Paramount Bed Holdings Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Paramount Bed Holdings Co (TSE:7817) Business Description

Traded in Other Exchanges
N/A
Address
14-5, Higashisuna, 2-chome, Koto-ku, Tokyo, JPN, 136-8671
Paramount Bed Holdings Co Ltd manufactures medical and nursing care products. Its acute care business sells products to intensive care units and other acute care facilities to relieve patient discomfort and prevent secondary infections. The long-term care business sells products used at long-term medical care facilities and nursing homes. The residential and nursing care business sells products to nurses and home-care helpers. The sleep and wellness business sells products to help customers sleep soundly, which include custom-made mattresses. The maintenance business provides bed maintenance and cleaning services. Paramount Bed generates the vast majority of its revenue in Japan.

Paramount Bed Holdings Co (TSE:7817) Headlines

No Headlines